Changing Landscape of DLBCL Treatment: ADCs, Bispecific Antibodies, CAR T Therapies, and Combinations – Enduring Webcast

Read more

Advances in the Treatment of Myelofibrosis: Clinical Trial Data of Next Generation Therapeutics – Live

Read more
3D illustration of human breast anatomy highlighting internal structures.

PI3K/ AKT/mTOR Pathway Inhibitors in the Treatment of HR+/HER2- Metastatic Breast Cancer – Enduring Webcast

Read more
CancerNet

Changing Landscape of DLBCL Treatment: ADCs, Bispecific Antibodies, CAR T Therapies, and Combinations – Live

Read more
CancerNet

Changing Landscape of Diagnosis and Personalized Therapies for Acute Myeloid Leukemia – Enduring Webcast

Read more
CancerNet

Changing Landscape of Diagnosis and Personalized Therapies for Acute Myeloid Leukemia – Live

Read more
CancerNet

Advances in the Treatment of Diffuse Large B Cell Lymphoma: ADCs, Bispecific Antibodies, CAR T Therapies and Combinations – Enduring Webcast

Read more
CancerNet

Myelofibrosis: Symptom Burden, Risk Stratification, and Novel Treatments – Enduring Webcast

Read more
CancerNet

Advances in the Treatment of Diffuse Large B Cell Lymphoma: ADCs, Bispecific Antibodies, CAR T Therapies and Combinations – Live

Read more
CancerNet

Myelofibrosis: Symptom Burden, Risk Stratification and Novel Treatments – Live

Read more
CancerNet

Evolving Paradigm of PARP-Inhibitors and Combination Therapies for mCRPC – Enduring Webcast

Read more
CancerNet

Changing Landscape of Diagnosis and Treatment Options for Multiple Myeloma – Enduring Webcast

Read more
CancerNet

Advances in Symptom Burden, Risk Stratification, and Treatment of Myelofibrosis – Enduring Webcast

Read more
CancerNet

Advances in Symptom Burden, Risk Stratification, and Treatment of Myelofibrosis – Live

Read more
CancerNet

New Strategies in the Diagnosis and Treatment of Follicular Lymphoma: 2022 ASH Update – Enduring Webcast

Read more
CancerNet

Immune Checkpoint and BRAF/MEK Inhibitor- directed Therapies for Advanced Melanoma – Enduring Webcast

Read more